Generex Biotechnology Corp (GNBTQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2020 | 10-2019 | 07-2019 | 04-2019 | 01-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -16,593 | -9,313 | -11,007 | -5,755 | 5,398 |
| Depreciation Amortization | 407 | 203 | 3,736 | 550 | 378 |
| Accounts receivable | -81 | 4 | -750 | 735 | 687 |
| Other Working Capital | 3,542 | 2,090 | 11,076 | 9,136 | 4,519 |
| Other Operating Activity | 8,104 | 5,171 | -12,629 | -12,725 | -14,953 |
| Operating Cash Flow | $-4,620 | $-1,844 | $-9,574 | $-8,058 | $-3,970 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -5 | -5 | 3 | -34 | -27 |
| Net Acquisitions | 49 | 49 | N/A | 2,280 | 1,723 |
| Purchase Sale Intangibles | N/A | N/A | 36 | 36 | -27 |
| Other Investing Activity | 0 | 0 | 2,316 | 36 | -26 |
| Investing Cash Flow | $45 | $45 | $2,319 | $2,282 | $1,670 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,372 | 2,977 | 6,560 | 5,927 | 3,521 |
| Debt Repayment | -936 | -936 | N/A | -27 | -29 |
| Common Stock Issued | 110 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | -52 | 229 | 134 |
| Financing Cash Flow | $4,546 | $2,041 | $6,509 | $6,128 | $3,626 |
| Exchange Rate Effect | N/A | 0 | -1 | 9 | 2 |
| Beginning Cash Position | 299 | 299 | 1,046 | 1,046 | 1,046 |
| End Cash Position | 269 | 540 | 299 | 1,408 | 2,374 |
| Net Cash Flow | $-29 | $242 | $-748 | $362 | $1,328 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,620 | -1,844 | -9,574 | -8,058 | -3,970 |
| Capital Expenditure | -5 | -5 | -290 | -286 | -27 |
| Free Cash Flow | -4,625 | -1,848 | -9,864 | -8,344 | -3,997 |